Department of Developmental Neurobiology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
Neuron. 2010 Sep 23;67(6):936-52. doi: 10.1016/j.neuron.2010.08.034.
Spinobulbar muscular atrophy (SBMA) is a neurodegenerative disease caused by expansion of a polyglutamine tract in the androgen receptor (AR). This mutation confers toxic function to AR through unknown mechanisms. Mutant AR toxicity requires binding of its hormone ligand, suggesting that pathogenesis involves ligand-induced changes in AR. However, whether toxicity is mediated by native AR function or a novel AR function is unknown. We systematically investigated events downstream of ligand-dependent AR activation in a Drosophila model of SBMA. We show that nuclear translocation of AR is necessary, but not sufficient, for toxicity and that DNA binding by AR is necessary for toxicity. Mutagenesis studies demonstrated that a functional AF-2 domain is essential for toxicity, a finding corroborated by a genetic screen that identified AF-2 interactors as dominant modifiers of degeneration. These findings indicate that SBMA pathogenesis is mediated by misappropriation of native protein function, a mechanism that may apply broadly to polyglutamine diseases.
脊髓延髓肌肉萎缩症(SBMA)是一种由雄激素受体(AR)中多聚谷氨酰胺链的扩展引起的神经退行性疾病。这种突变通过未知的机制赋予 AR 毒性功能。突变的 AR 毒性需要其激素配体的结合,这表明发病机制涉及 AR 配体诱导的变化。然而,毒性是由天然 AR 功能还是新的 AR 功能介导尚不清楚。我们在 SBMA 的果蝇模型中系统地研究了配体依赖性 AR 激活下游的事件。我们表明,AR 的核易位是毒性所必需的,但不是充分的,并且 AR 的 DNA 结合对于毒性是必需的。突变研究表明,功能性 AF-2 结构域对于毒性是必不可少的,这一发现得到了遗传筛选的证实,该筛选鉴定了 AF-2 相互作用者作为退化的显性修饰因子。这些发现表明,SBMA 的发病机制是由天然蛋白功能的不当利用介导的,这种机制可能广泛适用于多聚谷氨酰胺疾病。